S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Closing prices for crude oil, gold and other commodities
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Closing prices for crude oil, gold and other commodities
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Closing prices for crude oil, gold and other commodities
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Closing prices for crude oil, gold and other commodities
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show

Cognition Therapeutics (CGTX) Earnings Date, Estimates & Call Transcripts

$1.96
-0.13 (-6.22%)
(As of 05:21 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

CGTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CGTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cognition Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.98) EPS
Next Year EPS Consensus Estimate: ($1.38) EPS

CGTX Earnings Date and Information

Cognition Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Cognition Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
11/2/2023Q3 2023($0.31)($0.22)+$0.09($0.22)--
8/8/2023Q2 2023($0.25)($0.16)+$0.09($0.16)--
5/4/2023Q1 2023($0.17)($0.21)($0.04)($0.21)--
3/23/2023Q4 2022($0.49)($0.20)+$0.29($0.20)--
11/14/2022Q3 2022($0.55)($0.29)+$0.26($0.29)--
8/9/2022Q2 2022($0.31)($0.25)+$0.06($0.25)--
5/11/2022Q1 2022($0.27)($0.17)+$0.10($0.17)--  
11/16/2021Q3 2021($0.57)($8.12)($7.55)($8.12)--

Cognition Therapeutics Earnings - Frequently Asked Questions

When is Cognition Therapeutics's earnings date?

Cognition Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on CGTX's earnings history.

How much profit does Cognition Therapeutics generate each year?

Cognition Therapeutics (NASDAQ:CGTX) has a recorded net income of -$25.79 million. CGTX has generated -$0.86 earnings per share over the last four quarters.

What is Cognition Therapeutics's EPS forecast for next year?

Cognition Therapeutics's earnings are expected to decrease from ($0.98) per share to ($1.38) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CGTX) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners